|1.||Jones, Ronald N: 13 articles (04/2014 - 05/2002)|
|2.||Brook, Itzhak: 13 articles (11/2011 - 05/2002)|
|3.||Paterson, David L: 11 articles (01/2015 - 01/2004)|
|4.||Ko, Wen-Chien: 10 articles (12/2015 - 01/2004)|
|5.||Pitout, Johann D D: 10 articles (07/2011 - 06/2004)|
|6.||Bonomo, Robert A: 10 articles (07/2010 - 12/2002)|
|7.||Pascual, Alvaro: 10 articles (05/2010 - 03/2004)|
|8.||Hsueh, Po-Ren: 9 articles (02/2013 - 09/2003)|
|9.||Rodríguez-Baño, Jesús: 9 articles (05/2010 - 03/2004)|
|10.||Apisarnthanarak, Anucha: 9 articles (11/2008 - 03/2006)|
09/01/1984 - "Both drugs were very effective in the eradication of uncomplicated gonococcal infections caused by both non-beta-lactamase producing and beta-lactamase producing gonococci. "
03/01/1989 - "Clinical efficacies were judged to be good in 33 cases (97.1%) out of 34 which included 13 cases of 14 with infections caused by beta-lactamase-producing strains of organisms, and successfully cured by this drug. "
01/01/1987 - "Especially SPCM was effective for infections by PPNG, since it was not resolved by beta-lactamase of N. "
01/01/2006 - "This combination proved to be useful for the treatment of several infections caused by different microorganisms, mainly with the beta-lactamase-producing species. "
01/01/2005 - "However, the relative efficacy of these agents for chlamydial infection and the emergence of beta-lactamase-producing Neisseria gonorrheae has raised questions regarding their effectiveness when applied topically for prophylaxis of ON. "
06/01/1990 - "Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity."
03/01/2011 - "[Endocarditis caused by extended spectrum beta lactamase producing Klebsiella]."
05/01/2009 - "Prosthetic valve endocarditis caused by metallo-beta-lactamase-producing Pseudomonas aeruginosa."
04/01/2001 - "Nosocomial endocarditis due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a child."
11/01/1994 - "Endocarditis due to beta-lactamase-producing Cardiobacterium hominis."
|3.||Urinary Tract Infections (Urinary Tract Infection)
03/01/1989 - "In particular, 2 urinary tract infections caused by highly beta-lactamase producing Escherichia coli were improved by the treatment with SBT/ABPC. "
10/01/1984 - "In particular, 7 of 8 urinary tract infections caused by beta-lactamase producing organisms were improved after administration of SBT/CPZ. "
03/01/2015 - "Study of family physicians' practices in case of urinary tract infections caused by enterobacteriaceae secreting extended-spectrum-beta-lactamase."
03/01/2013 - "The appearance of extended- spectrum beta-lactamase (ESBL)-producing E.coli in urinary tract infections (UTI) constitutes an important therapeutic challenge that requires the study of its evolution throughout time in order to establish a suitable empirical treatment. "
02/01/2013 - "To study the clinical and laboratory characteristics of urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase (ESBL) producing Escherichia coli (E. "
04/01/1986 - "The drug was especially effective against the cases of pneumonia due to beta-lactamase-producing H. "
07/01/1985 - "ASPC was effective in all but 1 case of pneumonia due to beta-lactamase-positive H. "
01/01/2006 - "Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-beta-lactamase-mediated multidrug resistance: a prospective observational study."
08/01/2014 - "The detection rates of extended-spectrum beta-lactamase-producing Klebsiella pneumonia/Klebsiella oxytoca, Escherichia coli, and Proteus mirabilis were 24.0%, 87.9% and 38.4%, respectively. "
08/01/2013 - "pneumonia (n = 4), followed by extended-spectrum beta-lactamase-producing E. "
|5.||Bacterial Infections (Bacterial Infection)
09/01/2014 - "Metallo beta-lactamase (MBL) resistance in this bacterium has led some difficulties in treating bacterial infections. "
10/01/2010 - "beta-lactamases (penicillinases) are important complicating factors in bacterial infections and excellent theoretical and experimental models in protein structure, dynamics and evolution. "
07/01/2010 - "Beta-lactamase-mediated antibiotic resistance continues to challenge the contemporary treatment of serious bacterial infections. "
02/01/2000 - "beta-Lactamase inhibitor:beta-lactam combinations remain one of the most successful strategies for the treatment of bacterial infections. "
06/01/1998 - "Beta-lactam/beta-lactamase inhibitor combinations: pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic host."
|3.||Clavulanic Acid (Potassium Clavulanate)
|4.||Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)
|8.||Cephalosporins (Cephalosporin Antibiotics)
|9.||Anti-Bacterial Agents (Antibiotics)
|3.||Intensive Care (Surgical Intensive Care)
|4.||Neonatal Intensive Care